Bk-MDEA

Bk-MDEA

Bk-MDEA (also known as Ethylone or 3,4-Methylenedioxy-N-ethylcathinone) is a psychoactive drug and member of the phenethylamine, amphetamine, and cathinone chemical classes. It is the β-keto analogue of MDEA ("Eve"). Bk-MDEA shares many of the same chemical properties as MDMA and is often considered as a substitute for MDMA due to its legal status and lower health risks.

Chemistry

Bk-MDEA is a synthetic cathinone. Cathinones are a sub-category of amphetamine, sharing the core amphetamine structure of a phenyl ring bound to an amino (NH2) group through an ethyl chain with an additional methyl substitution at Rα. Bk-MDEA features a phenethylamine core with an alkyl group attached to the alpha carbon, and a ketone group attached to the beta carbon. It is most commonly found in the form of its hydrochloride salt, a fluffy, white powder.

Pharmacology

Bk-MDEA acts as a mixed reuptake inhibitor/releasing agent of serotonin, norepinephrine, and dopamine. These are the neurotransmitters in charge of pleasure, reward, and motivation, and their interaction with Bk-MDEA is what leads to its psychoactive effects.

Effects

The effects of Bk-MDEA are described as a mix between MDMA and methylone, producing feelings of euphoria, empathy, and love, as well as increased awareness of the senses. However, it is also associated with negative effects such as anxiety, paranoia, and in rare cases, psychosis.

Legal Status

The legal status of Bk-MDEA varies by country. In the United States, it is a Schedule I controlled substance. In the United Kingdom, it is a Class B drug under the Misuse of Drugs Act 1971.

See Also

• MDMA
• Methylone
• Cathinone
• Amphetamine
• Phenethylamine